MacPhee John A 4
4 · Adamas Pharmaceuticals Inc · Filed Mar 16, 2021
Insider Transaction Report
Form 4
MacPhee John A
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-12−192,000→ 0 totalExercise: $0.67Exp: 2021-11-15→ Common Stock (192,000 underlying) - Exercise/Conversion
Common Stock
2021-03-12$0.67/sh+192,000$127,680→ 197,000 total
Footnotes (1)
- [F1]Fully vested.